Skip to content

Sugammadex Impurity 24

Sugammadex Impurity 24

Product Description
CAT No.
ALN-S029070
CAS No.
NA
Mol. F.
C75H116O49S9
Mol. Wt.
2090.2
Stock
Please Inquire
Smiles : OC([C@H]1O)[C@H](OC2O[C@H](CSCCC(O)=O)[C@@H](O3)[C@@H](O)[C@H]2O)[C@@H](CSCCC(O)=O)O[C@@H]1O[C@@H]([C@@H](SCCC(O)=O)[C@H]4O)[C@@H](CSCCC(O)=O)OC4O[C@@H](C(O)[C@H]5O)[C@@H](CSCCC(O)=O)OC5O[C@@H](C(O)[C@H]6O)[C@@H](CSCCC(O)=O)O[C@@H]6O[C@@H](C(O)[C@H]7O)[C@@H](CSCCC(O)=O)O[C@@H]7O[C@@H](C(O)[C@H]8O)[C@@H](CSCCC(O)=O)O[C@@H]8O[C@@H]9[C@@H](CSCCC(O)=O)O[C@@H]3[C@H](O)C9O

Analytical method development and validation for the estimation of sugammadex

By Parekh, Hemangi; Chokshi, Parin; Mashru, RajashreenFrom Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.

Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay

By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H – From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.

Request For Quotation